The Medical Investor, written by Phase 1 Investor editor Rob Fannon and biotechnology expert Dr. George Huang, focuses on the best health care investments in today's stock market.

Rob has been the secret behind some of Stansberry Research's best medical recommendations over the years - including Sirna (203% gain) and ID Biomedical (331% gain).

Rob has considerable experience in business and science: He holds a master’s degree in public health and an MBA, both from Johns Hopkins University.

George holds a PhD from Johns Hopkins' School of Medicine, where he worked under a 2003 Nobel Laureate in chemistry.

They've each spent hundreds of hours in the lab doing in-depth research, contracting with the National Institutes of Health (NIH), and working side-by-side with scientists and doctors at the best universities and hospitals in the country.

Together, Rob and George make an unbeatable team for picking the safest, most profitable medical investments in the stock market.